CK1 Antibody KRT1/1840 / Cytokeratin 1 Monoclonal Antibody [clone KRT1/1840] (V7908)

CK1 Antibody KRT1/1840 by IHC in Human Cervical Carcinoma. Immunohistochemistry of FFPE human cervical carcinoma tissue using CK1 Antibody KRT1/1840. Moderate to strong brown DAB staining is observed predominantly in the cytoplasm of differentiated squamous epithelial cells, with stronger staining toward the superficial regions and weaker staining in the underlying cells. The Cytokeratin 1 Monoclonal Antibody highlights the differentiation-associated expression of KRT1 in squamous epithelium. Nuclei are counterstained blue with hematoxylin. Heat-induced epitope retrieval was performed using 10 mM Tris with 1 mM EDTA, pH 9, for 20 minutes, followed by cooling before antibody incubation.

CK1 Antibody KRT1/1840 by IHC in Human Skin. Immunohistochemistry of FFPE human skin tissue using CK1 Antibody KRT1/1840. Strong brown DAB staining is observed throughout the suprabasal epidermal layers, while the basal keratinocytes show comparatively little staining. The Cytokeratin 1 Monoclonal Antibody demonstrates the characteristic distribution of KRT1 in differentiating keratinocytes, consistent with its role in epidermal intermediate filament organization. Nuclei are counterstained blue with hematoxylin. Heat-induced epitope retrieval was performed using 10 mM Tris with 1 mM EDTA, pH 9, for 20 minutes, followed by cooling before antibody incubation.

CK1 Antibody KRT1/1840 by SDS-PAGE. SDS-PAGE analysis of purified, BSA-free CK1 Antibody KRT1/1840, with 2 ug of antibody loaded per lane. The non-reducing (NR) lane shows a prominent band at approximately 150 kDa, consistent with intact IgG. The reducing (R) lane is faint, with no clearly resolved heavy and light chains visible in the displayed image. The non-reducing band supports the integrity of the purified mouse monoclonal antibody preparation.